TAK1 in brain endothelial cells mediates fever and lethargy

被引:89
|
作者
Ridder, Dirk A. [1 ,2 ]
Lang, Ming-Fei [2 ]
Salinin, Sergei [1 ,2 ]
Roederer, Jan-Peter [2 ]
Struss, Marcel [1 ]
Maser-Gluth, Christiane [2 ]
Schwaninger, Markus [1 ,2 ]
机构
[1] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, D-23562 Lubeck, Germany
[2] Univ Heidelberg, Inst Pharmacol, D-69117 Heidelberg, Germany
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2011年 / 208卷 / 13期
关键词
NF-KAPPA-B; BACTERIAL LIPOPOLYSACCHARIDE; INDUCED ANOREXIA; INFLAMMATION; INTERLEUKIN-1; EXPRESSION; SECRETION; CYTOKINES; RESPONSES; SICKNESS;
D O I
10.1084/jem.20110398
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic inflammation affects the brain, resulting in fever, anorexia, lethargy, and activation of the hypothalamus-pituitary-adrenal axis. How peripheral inflammatory signals reach the brain is still a matter of debate. One possibility is that, in response to inflammatory stimuli, brain endothelial cells in proximity to the thermoregulatory centers produce cyclooxygenase 2 (COX-2) and release prostaglandin E2, causing fever and sickness behavior. We show that expression of the MAP kinase kinase kinase TAK1 in brain endothelial cells is needed for interleukin 1 beta (IL-1 beta)-induced COX-2 production. Exploiting the selective expression of the thyroxine transporter Slco1c1 in brain endothelial cells, we generated a mouse line allowing inducible deletion of Tak1 specifically in brain endothelium. Mice lacking the Tak1 gene in brain endothelial cells showed a blunted fever response and reduced lethargy upon intravenous injection of the endogenous pyrogen IL-1 beta. In conclusion, we demonstrate that TAK1 in brain endothelial cells induces COX-2, most likely by activating p38 MAPK and c-Jun, and is necessary for fever and sickness behavior.
引用
收藏
页码:2615 / 2623
页数:9
相关论文
共 50 条
  • [21] Enterohemorrhagic Escherichia coli Tir inhibits TAK1 activation and mediates immune evasion
    Zhou, Ruixue
    Chen, Zijuan
    Hao, Doudou
    Wang, Yu
    Zhang, Yihua
    Yi, Xianfu
    Lyu, Liang-Dong
    Liu, Haipeng
    Zou, Quanming
    Chu, Yiwei
    Ge, Baoxue
    Yan, Dapeng
    EMERGING MICROBES & INFECTIONS, 2019, 8 (01) : 734 - 748
  • [22] TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
    Takaesu, G
    Kishida, S
    Hiyama, A
    Yamaguchi, K
    Shibuya, H
    Irie, K
    Ninomiya-Tsuji, J
    Matsumoto, K
    MOLECULAR CELL, 2000, 5 (04) : 649 - 658
  • [23] TAK1 control of cell death
    Mihaly, S. R.
    Ninomiya-Tsuji, J.
    Morioka, S.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (11): : 1667 - 1676
  • [24] Ubiquitin, TAK1 and IKK: is there a connection?
    Z J Chen
    V Bhoj
    R B Seth
    Cell Death & Differentiation, 2006, 13 : 687 - 692
  • [25] TAK1 INHIBITION BY A TYPE II
    Davis, Mindy I.
    Simeonov, Anton
    Lea, Wendy
    Auld, Doug
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2015, 13 (01) : 2 - 10
  • [26] TAK1 control of cell death
    S R Mihaly
    J Ninomiya-Tsuji
    S Morioka
    Cell Death & Differentiation, 2014, 21 : 1667 - 1676
  • [27] Ubiquitin, TAK1 and IKK: is there a connection?
    Chen, ZJ
    Bhoj, V
    Seth, RB
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (05): : 687 - 692
  • [28] TGF-β1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1
    Dvashi, Zeev
    Goldberg, Mordechai
    Adir, Orit
    Shapira, Michal
    Pollack, Ayala
    PLOS ONE, 2015, 10 (04):
  • [29] Downregulation of TAK1 Inhibit Migration and Invasion in Neuroendocrine Tumor Cells
    Yang, X.
    Tang, Q.
    NEUROENDOCRINOLOGY, 2019, 108 : 22 - 22
  • [30] Survival and maintenance of regulatory T cells require the kinase TAK1
    Chang, Jae-Hoon
    Hu, Hongbo
    Sun, Shao-Cong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (05) : 572 - 579